HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Benjamin Pradere Selected Research

Cisplatin (Platino)

5/2023Carboplatin Induction Chemotherapy in Clinically Lymph Node-positive Bladder Cancer.
12/2022Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer.
2/2021Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis.
1/2021Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Benjamin Pradere Research Topics

Disease

54Carcinoma (Carcinomatosis)
03/2024 - 01/2020
46Neoplasms (Cancer)
05/2024 - 07/2018
45Urinary Bladder Neoplasms (Bladder Cancer)
04/2024 - 01/2020
34Prostatic Neoplasms (Prostate Cancer)
04/2024 - 08/2020
25Non-Muscle Invasive Bladder Neoplasms
01/2024 - 01/2020
16Neoplasm Metastasis (Metastasis)
05/2024 - 06/2018
16Renal Cell Carcinoma (Grawitz Tumor)
04/2024 - 06/2018
8Inflammation (Inflammations)
03/2024 - 09/2021
7Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
10/2023 - 07/2018
7Lymphatic Metastasis
05/2023 - 11/2021
5Wounds and Injuries (Trauma)
01/2023 - 01/2020
3Margins of Excision
11/2023 - 01/2018
3Disease Progression
10/2023 - 01/2021
3Infections
01/2021 - 01/2019
3COVID-19
01/2021 - 10/2020
2Diabetes Mellitus
11/2023 - 12/2017
2Erectile Dysfunction
08/2023 - 04/2021
2Urologic Neoplasms (Urological Cancer)
01/2023 - 11/2022
2Hemorrhage
01/2022 - 08/2019
2Overactive Urinary Bladder (Overactive Bladder)
01/2022 - 09/2021
2Lower Urinary Tract Symptoms
11/2021 - 09/2021
2Anemia
01/2021 - 01/2021
2Febrile Neutropenia
01/2021 - 01/2021
2Fatigue
01/2021 - 01/2021
1Cystitis
03/2024
1Venous Thromboembolism
03/2024
1Hypertension (High Blood Pressure)
11/2023
1Necrosis
11/2023
1Pain (Aches)
08/2023

Drug/Important Bio-Agent (IBA)

18Biomarkers (Surrogate Marker)IBA
11/2023 - 01/2020
13Immune Checkpoint InhibitorsIBA
04/2024 - 01/2021
8GlobulinsIBA
03/2022 - 01/2021
7AndrogensIBA
04/2024 - 01/2021
7Androgen Receptors (Androgen Receptor)IBA
04/2024 - 11/2020
7AlbuminsIBA
01/2023 - 01/2021
6Docetaxel (Taxotere)FDA Link
04/2024 - 01/2022
6Serum AlbuminIBA
10/2021 - 01/2021
5NivolumabIBA
04/2024 - 01/2022
5Hormones (Hormone)IBA
04/2024 - 01/2022
5GemcitabineFDA Link
05/2023 - 01/2021
4Cisplatin (Platino)FDA LinkGeneric
05/2023 - 01/2021
4PlatinumIBA
02/2023 - 01/2021
3Hemoglobins (Hemoglobin)IBA
11/2023 - 08/2019
3pembrolizumabIBA
10/2023 - 01/2022
3Mitomycin (Mitomycin-C)FDA LinkGeneric
05/2023 - 01/2020
3darolutamideIBA
01/2023 - 11/2020
3Prostate-Specific Antigen (Semenogelase)IBA
01/2023 - 11/2020
3enzalutamideIBA
12/2022 - 11/2020
3Tyrosine Kinase InhibitorsIBA
01/2022 - 10/2021
2cabozantinibIBA
04/2024 - 10/2023
2IpilimumabIBA
04/2024 - 10/2023
25-alpha Reductase InhibitorsIBA
10/2023 - 10/2023
2Carboplatin (JM8)FDA LinkGeneric
05/2023 - 11/2022
2C-Reactive ProteinIBA
01/2023 - 01/2022
2Indicators and Reagents (Reagents)IBA
01/2023 - 11/2020
2apalutamideIBA
12/2022 - 11/2020
2DNA (Deoxyribonucleic Acid)IBA
11/2022 - 01/2020
2AntigensIBA
01/2022 - 12/2020
2ClaudinsIBA
01/2022 - 01/2021
2Phenobarbital (Luminal)FDA Link
01/2022 - 01/2021
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2021 - 01/2021
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2021 - 12/2020
2Alanine Transaminase (SGPT)IBA
06/2021 - 12/2020
2dimemorfan (AT 17)IBA
03/2021 - 04/2020
2AerosolsIBA
01/2021 - 01/2021
2mesoglycanIBA
12/2020 - 11/2020
1GlycosaminoglycansIBA
03/2024
1Hyaluronic Acid (Hyaluronan)IBA
03/2024
1PotassiumIBA
03/2024
1IonsIBA
03/2024
1ChondroitinIBA
03/2024
1Kallikreins (Kallikrein)IBA
11/2023
1Phosphodiesterase 5 InhibitorsIBA
08/2023
1Cholinesterases (Cholinesterase)IBA
07/2023
1ElementsIBA
06/2023

Therapy/Procedure

50Therapeutics
05/2024 - 01/2019
37Cystectomy
04/2024 - 01/2020
19Nephroureterectomy
03/2024 - 09/2020
19Drug Therapy (Chemotherapy)
01/2024 - 01/2020
16Immunotherapy
04/2024 - 01/2020
15Neoadjuvant Therapy
01/2024 - 01/2021
14Nephrectomy
11/2023 - 06/2018
14Prostatectomy (Retropubic Prostatectomy)
01/2023 - 10/2020
13Transurethral Resection of Bladder
10/2023 - 01/2021
8Castration
10/2023 - 11/2020
7Lymph Node Excision (Lymph Node Dissection)
03/2024 - 01/2021
5Urinary Diversion (Ileal Conduit)
09/2023 - 11/2020
4Length of Stay
09/2023 - 01/2018
4Adjuvant Chemotherapy
12/2022 - 06/2020
4Radiotherapy
03/2022 - 10/2020
3Combination Drug Therapy (Combination Chemotherapy)
02/2023 - 01/2021
3Transurethral Resection of Prostate (TURP)
01/2023 - 07/2018
2Induction Chemotherapy
03/2024 - 05/2023
2Enhanced Recovery After Surgery
11/2022 - 11/2020
2Precision Medicine
01/2022 - 01/2021
2Minimally Invasive Surgical Procedures
01/2021 - 01/2021
2Lasers (Laser)
02/2019 - 07/2018
1Combined Modality Therapy
05/2024
1Patient Readmission
03/2024
1Traction
08/2023